Elevated levels of CRP and D-dimer in patients with COVID-19 are also associated with an increased risk of thrombosis (Dujardin et al., 2020), poor prognosis, acute kidney injury, venous thromboembolism, death, and progression to critical illness (Smilowitz et al., 2021). The gene discussed is CRP; the disease is venous thromboembolism.